. We therefore decided to increase the dosage of tinzaparin by 50% (about 75 U anti-Xa/kg BW), and, to preserve an acceptable safety profile, we decided to give the first injection in the evening before (12 h) rather than on the morning of the operation (2 h).
Summary: This is a review of a double-blind, prospective and after the operation; all bleeding complications, reoperastudy comparing the 
RESULTS

Efficacy
After randomization, 5 tected between the groups in terms of the total number of transfusions required. Data on the evolution of the surgical wound is shown in Table 7 . A significantly higher proportion of patients on regimen 2 had unusual wound evolution compared with patients on regimen 1 (26.6% versus 13.2%) (P = 0.011 ). The change in platelet count from baseline showed no statistically significant treatment effect between the groups, and no patients developed signs of heparin-induced thrombocytopenia. There was no statistically significant difference between the groups in terms of the proportion of patients experiencing at least one adverse event or the highest severity rating of adverse events. The rationale for using a dosage of 50 U anti-Xa/kg BW of tinzaparin in elective hip surgery was originally based on 2 clinical studies in which the first dosage was given 2 h before operation for all subjects (6, 7) . A pilot study including 10 THA patients using a dosage of 35 U anti-Xa/kg BW once daily, in which no phlebographically verified thrombosis or bleeding complications were noted, was followed by a large scale clinical study performed in 100 THA patients comparing this regimen of tinzaparin with a standard regimen of dextran 70 in an unblinded fashion. The result showed a non-significant difference in the overall DVT rate between the tinzaparin patients and the dextran patients (28% compared with 39%) leading to the conclusion that the dosage of tinzaparin should be increased (6) . Therefore, in the next study, dextran 70 was again compared with tinzaparin now in a dosage increased to 50 U anti-Xa/kg BW, which resulted in a significant reduction of the overall DVT rate (17% compared with 29%) without safety problems (7) . Therefore, 50 U anti-Xa/kg BW started 2 hours before operation became the recommended dosage regimen of tinzaparin in patients undergoing hip surgery. A biologic quibble may play a part in the improved antithrombotic potency of the new regimen. For reasons that are not known, the PAI-1 activity is influenced by circadian variations, and, therefore, the activity is highest in the morning and lowest in the evening. As a consequence, the t-PA activity, the fibrinolytic capacity, is lowest in the morning and highest in the evening (8) .
When the first injection is given in the evening, it is possible that the fibrinolytic capacity is more optimal at the time of operation because the peak activity of the heparin has then been reached due to release of t-PA from the endothelium, which is not true when the first injection is given in the morning.
We achieved the gain in efficacy without a loss of safety. We 
